檢索結果 - Max Yu-Chen Pan
- Showing 1 - 2 results of 2
-
1
Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2 由 Richard Kuan‐Lin Lee, Tian‐Neng Li, Sui‐Yuan Chang, Tai‐Ling Chao, Chun-Hsien Kuo, Max Yu-Chen Pan, Yu-Ting Chiou, Kuan-Ju Liao, Yi Yang, Yi‐Hsuan Wu, Chen-Hao Huang, Hsueh‐Fen Juan, Hsing‐Pang Hsieh, Lily Wang
出版 2022Artigo -
2
TRUST-II: a global phase II study of taletrectinib in <i>ROS1</i> -positive non-small-cell lung cancer and other solid tumors 由 Misako Nagasaka, Yuichiro Ohe, Caicun Zhou, Chang‐Min Choi, Nong Yang, Geoffrey Liu, Enriqueta Felip, M. Pérol, Benjamin Besse, Jorge J. Nieva, Luis E. Raez, Nathan A. Pennell, Anastasios Dimou, Filippo de Marinis, Fortunato Ciardiello, Takashi Seto, Zheyi Hu, Max Yu-Chen Pan, Weiqing Wang, Shuanglian Li, Sai‐Hong Ignatius Ou
出版 2023Artigo
相關主題
Medicine
Adenocarcinoma
Adverse effect
Antiretroviral therapy
Biology
Brain metastasis
Cancer
Chemistry
Clinical endpoint
Clinical trial
Coronavirus
Coronavirus disease 2019 (COVID-19)
Crizotinib
Disease
Dolutegravir
Etravirine
Infectious disease (medical specialty)
Interim analysis
Internal medicine
Lung cancer
Malignant pleural effusion
Metastasis
Oncology
Pathology
Pharmacology
ROS1
Vero cell
Viral entry
Viral load
Viral replication